相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors
Kazuki Takada et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy
Mehmet Asim Bilen et al.
ONCOLOGIST (2020)
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study
Alessio Cortellini et al.
SCIENTIFIC REPORTS (2020)
Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors
Benoit Roch et al.
LUNG CANCER (2020)
Development and Validation of a Deep Learning System for Segmentation of Abdominal Muscle and Fat on Computed Tomography
Hyo Jung Park et al.
KOREAN JOURNAL OF RADIOLOGY (2020)
Sarcopenia: revised European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2019)
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
Saori Mishima et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Clinical Impact of Sarcopenia on Gastric Cancer
Kazuya Kuwada et al.
ANTICANCER RESEARCH (2019)
Semiautomatic software for measurement of abdominal muscle and adipose areas using computed tomography A STROBE-compliant article
Seung Soo Kim et al.
MEDICINE (2019)
Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer
Naoya Nishioka et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Advances in cancer immunotherapy 2019-latest trends
Stephan Kruger et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia
Joanna D. C. C. Lima et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Skeletal muscle as potential central link between sarcopenia and immune senescence
Christopher Nelke et al.
EBIOMEDICINE (2019)
Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis
Sivesh K. Kamarajah et al.
GASTRIC CANCER (2019)
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
Takayuki Shiroyama et al.
SCIENTIFIC REPORTS (2019)
TGF-beta requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy
Johanna Abrigo et al.
BIOLOGICAL CHEMISTRY (2018)
Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment
Hirotake Tsukamoto et al.
CANCER RESEARCH (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer
Jong Soo Lee et al.
PLOS ONE (2018)
Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
Seong Hee Kang et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET (2017)
Inflammation and sarcopenia: A systematic review and meta-analysis
Giulia Bano et al.
MATURITAS (2017)
Age-specific impact on the survival of gastric cancer patients with distant metastasis: an analysis of SEER database
Xinxing Li et al.
Oncotarget (2017)
The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
Louise E. Daly et al.
BRITISH JOURNAL OF CANCER (2017)
Sarcopenia Adversely Impacts Postoperative Clinical Outcomes Following Gastrectomy in Patients with Gastric Cancer: A Prospective Study
Su-Lin Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer
Hae Won Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy
Laurent Dercle et al.
EUROPEAN JOURNAL OF CANCER (2016)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
Sarcopenia is an Independent Predictor of Severe Postoperative Complications and Long-Term Survival After Radical Gastrectomy for Gastric Cancer Analysis from a Large-Scale Cohort
Cheng-Le Zhuang et al.
MEDICINE (2016)
Inflammation induced loss of skeletal muscle
Priya Londhe et al.
BONE (2015)
Sarcopenia Is Highly Prevalent in Patients Undergoing Surgery for Gastric Cancer But Not Associated With Worse Outcomes
Juul J. W. Tegels et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications
Nicolas J. Pillon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Host Inflammatory Response Predicts Survival of Patients With Epstein-Barr Virus-Associated Gastric Carcinoma
Hye-Jong Song et al.
GASTROENTEROLOGY (2010)
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
Digant Gupta et al.
NUTRITION JOURNAL (2010)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Clinicopathological Aspects and Prognostic Value With Respect to Age: An Analysis of 3,362 Consecutive Gastric Cancer Patients
Jun Chul Park et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
H-T Arkenau et al.
BRITISH JOURNAL OF CANCER (2008)
Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma
J. Lee et al.
ANNALS OF ONCOLOGY (2007)
Serum albumin as a significant prognostic factor for patients with gastric carcinoma
Luis F. Onate-Ocana et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Laura A. Schaap et al.
AMERICAN JOURNAL OF MEDICINE (2006)
分享论文
